The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 13,120 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| ALLSCRIPTS HEALTHCARE SOLUTN | COM | 01988P108 | 1,914 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 8,375 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| AMYRIS INC | COM NEW | 03236M200 | 1,590 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 7,652 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 6,828 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 13,934 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 12,172 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 6,486 | 1,190,000 | SH | SOLE | 1,190,000 | 0 | 0 | ||
| CURIS INC | COM | 231269101 | 161 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 2,751 | 177,500 | SH | SOLE | 177,500 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 2,237 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 7,852 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| EVOLENT HEALTH INC | CL A | 30050B101 | 13,182 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 1,782 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 19,080 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 8,104 | 685,000 | SH | SOLE | 685,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 5,309 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 4,247 | 60,000 | SH | Call | SOLE | 60,000 | 0 | 0 | |
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 5,880 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 5,466 | 31,500 | SH | SOLE | 31,500 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 2,245 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 9,330 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 28,868 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 5,175 | 395,000 | SH | SOLE | 395,000 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 2,584 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| OVID THERAPEUTICS INC | COM | 690469101 | 2,326 | 221,700 | SH | SOLE | 221,700 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 1,068 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 20,308 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 12,320 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 10,156 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 11,577 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 2,931 | 182,141 | SH | SOLE | 182,141 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 6,713 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 6,630 | 740,000 | SH | SOLE | 740,000 | 0 | 0 | ||